ExploreWatchlistsPricing
  1. US-listed companies
  2. Panbela Therapeutics, Inc.
  3. Financials
  4. Effective tax rate (%)

Panbela Therapeutics, Inc. (PBLA)

Market cap
$4.85
P/E ratio
SummaryFinancials
Period EndEffective tax rate (%) (Million USD)YoY (%)
Dec 31, 20230.7+120.83%
Dec 31, 20220.3-92.80%
Dec 31, 20214.6-21.16%
Dec 31, 20205.8-7.13%
Dec 31, 20196.3+52.12%
Dec 31, 20184.1-16.06%
Dec 31, 20174.9-21.44%
Dec 31, 20166.3-52.99%
Dec 31, 201513.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat